Shandong Xinhua Pharmaceutical (00719) said its net profits attributable to the shareholders for the first quarter of 2017 surged 153.98% year-on-year to Rmb51.55 million.
Basic and diluted earnings per share were Rmb0.11.
Operating income amounted to Rmb1,295 million, an increase of 28.91% from a year earlier.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
